Search alternatives:
significantly small » significantly smaller (Expand Search), significantly impact (Expand Search), significantly impair (Expand Search)
greater disease » greater distance (Expand Search), greater decrease (Expand Search), related disease (Expand Search)
larger decrease » marked decrease (Expand Search)
Showing 181 - 200 results of 18,299 for search '(( significantly ((greater disease) OR (larger decrease)) ) OR ( significantly small decrease ))*', query time: 0.27s Refine Results
  1. 181
    Inhibition of PLK1 by BI 2536 did not significantly affect the kinetics of PIV5-W3 protein synthesis inhibition.

    Inhibition of PLK1 by BI 2536 did not significantly affect the kinetics of PIV5-W3 protein synthesis inhibition. by Dan F. Young (6321425)

    Published 2024
    Save to List
    Saved in:
  2. 182
    Expression of FcμR positive cells in small intestinal lymph nodes.

    Expression of FcμR positive cells in small intestinal lymph nodes. by Xie Fei (6740372)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  3. 183
    Variable sources of agar formulations have significant differences in stiffness.

    Variable sources of agar formulations have significant differences in stiffness. by Maria Oorloff (19658113)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 184
    Exposure to biologics during pregnancy does not affect placental antibody transfer of anti-SARS-CoV-2 neutralizing antibodies, but concomitant corticosteroid exposure may decrease antibody transfer.

    Exposure to biologics during pregnancy does not affect placental antibody transfer of anti-SARS-CoV-2 neutralizing antibodies, but concomitant corticosteroid exposure may decrease... by Donna E. Leet (22772478)

    Published 2025
    Save to List
    Saved in:
  5. 185
    Decreased expression of Nrf2 related genes and stemness markers in Nrf2 knocked down resistant Huh7 cells treated with siRNA.

    Decreased expression of Nrf2 related genes and stemness markers in Nrf2 knocked down resistant Huh7 cells treated with siRNA. by Luping Gao (4269754)

    Published 2021
    Save to List
    Saved in:
  6. 186
    PD-1 deficiency does not significantly impact the pathogen load and pathology following <i>S</i>. <i>japonicum</i> infection.

    PD-1 deficiency does not significantly impact the pathogen load and pathology following <i>S</i>. <i>japonicum</i> infection. by Liaoxun Lu (179293)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  7. 187
    Independent lead SNPs and SNPs tagged within each significant genomic locus for GSEM AD.

    Independent lead SNPs and SNPs tagged within each significant genomic locus for GSEM AD. by Javier de la Fuente (4794639)

    Published 2022
    Save to List
    Saved in:
  8. 188
    Significant t test for information about drugs used to treat the virus and professional degree.

    Significant t test for information about drugs used to treat the virus and professional degree. by Claudiu Coman (848250)

    Published 2022
    Save to List
    Saved in:
  9. 189
    County-level geographical septile distribution for the first 12 statistically significant factors with at least one statistically significant coefficient ranked by decreasing ΔIC.

    County-level geographical septile distribution for the first 12 statistically significant factors with at least one statistically significant coefficient ranked by decreasing ΔIC. by Yanan Long (11784717)

    Published 2021
    Save to List
    Saved in:
  10. 190
    No significant difference in the level of viral adaptation to HLA-restricted immune response across HIV genome.

    No significant difference in the level of viral adaptation to HLA-restricted immune response across HIV genome. by Marwah Al-kaabi (19010040)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 191
    Baseline clinical characteristics of study participants.

    Baseline clinical characteristics of study participants. by Hiroki Okabe (14425179)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  12. 192
    Description of quantitative assessment by OCT.

    Description of quantitative assessment by OCT. by Hiroki Okabe (14425179)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  13. 193
    Baseline clinical characteristics of patients who were followed up for 6 months.

    Baseline clinical characteristics of patients who were followed up for 6 months. by Hiroki Okabe (14425179)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  14. 194
    OCT findings of culprit lesions at 6-months follow-up.

    OCT findings of culprit lesions at 6-months follow-up. by Hiroki Okabe (14425179)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  15. 195
    Description of non-culprit lesion.

    Description of non-culprit lesion. by Hiroki Okabe (14425179)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  16. 196
    Predictors for progression of vascular calcification.

    Predictors for progression of vascular calcification. by Hiroki Okabe (14425179)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  17. 197
    Flow chart of the study design.

    Flow chart of the study design. by Hiroki Okabe (14425179)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  18. 198
    OCT findings of non-culprit lesions.

    OCT findings of non-culprit lesions. by Hiroki Okabe (14425179)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 199
    Baseline pre-PCI OCT findings of the culprit lesions.

    Baseline pre-PCI OCT findings of the culprit lesions. by Hiroki Okabe (14425179)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  20. 200
    Predictors of progression of lipid plaques.

    Predictors of progression of lipid plaques. by Hiroki Okabe (14425179)

    Published 2023
    Subjects:
    Save to List
    Saved in:

Search Tools: